Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction of Migraine Attacks With Aura Using PACAP-38
NCT07342296Not yet recruiting
- Sponsor
- Dansk Hovedpinecenter
- Start
- Feb 2026
- Primary completion
- Dec 2026
- Modality
- Peptides
01
Overview
Randomised, double-blind trial in migraine with aura comparing PACAP-38 with Placebo (2 arms). Primary endpoint: Incidence of migraine attacks with aura at 12 hours. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
pituitary adenylate cyclase-activating polypeptide-38
03
Conditions
migraine with aura
Beyond the preview
Go deeper on NCT07342296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07342296.